JP2005526147A - 局所組成物、局所組成物前駆体、並びに、その製造および使用方法 - Google Patents
局所組成物、局所組成物前駆体、並びに、その製造および使用方法 Download PDFInfo
- Publication number
- JP2005526147A JP2005526147A JP2003520779A JP2003520779A JP2005526147A JP 2005526147 A JP2005526147 A JP 2005526147A JP 2003520779 A JP2003520779 A JP 2003520779A JP 2003520779 A JP2003520779 A JP 2003520779A JP 2005526147 A JP2005526147 A JP 2005526147A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- topical composition
- weight
- alkylene
- topical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 304
- 230000000699 topical effect Effects 0.000 title claims abstract description 131
- 239000002243 precursor Substances 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims abstract description 23
- 229920000642 polymer Polymers 0.000 claims abstract description 92
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 79
- 229920001600 hydrophobic polymer Polymers 0.000 claims abstract description 59
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 54
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 26
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims abstract description 22
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 17
- 238000010128 melt processing Methods 0.000 claims abstract description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 12
- 238000007865 diluting Methods 0.000 claims abstract description 6
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 57
- 239000004094 surface-active agent Substances 0.000 claims description 45
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 43
- 239000004480 active ingredient Substances 0.000 claims description 29
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 17
- 229920000858 Cyclodextrin Polymers 0.000 claims description 17
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 15
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 15
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 15
- 229920002472 Starch Polymers 0.000 claims description 13
- 235000019698 starch Nutrition 0.000 claims description 13
- 229920002307 Dextran Polymers 0.000 claims description 12
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 12
- 229920002125 Sokalan® Polymers 0.000 claims description 12
- 229920001577 copolymer Polymers 0.000 claims description 12
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 12
- 239000011976 maleic acid Substances 0.000 claims description 12
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 12
- 229920002678 cellulose Polymers 0.000 claims description 11
- 239000001913 cellulose Substances 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 239000008107 starch Substances 0.000 claims description 11
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims description 10
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 9
- GQEZCXVZFLOKMC-UHFFFAOYSA-N 1-hexadecene Chemical compound CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 claims description 8
- 229920000881 Modified starch Polymers 0.000 claims description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 8
- 229940121375 antifungal agent Drugs 0.000 claims description 8
- 125000000524 functional group Chemical group 0.000 claims description 8
- 235000019426 modified starch Nutrition 0.000 claims description 8
- VAMFXQBUQXONLZ-UHFFFAOYSA-N n-alpha-eicosene Natural products CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 claims description 8
- 230000000475 sunscreen effect Effects 0.000 claims description 8
- 239000000516 sunscreening agent Substances 0.000 claims description 8
- 238000004132 cross linking Methods 0.000 claims description 7
- 239000004584 polyacrylic acid Substances 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 6
- 230000001747 exhibiting effect Effects 0.000 claims description 5
- 239000003205 fragrance Substances 0.000 claims description 5
- 239000000049 pigment Substances 0.000 claims description 5
- 229940106006 1-eicosene Drugs 0.000 claims description 4
- FIKTURVKRGQNQD-UHFFFAOYSA-N 1-eicosene Natural products CCCCCCCCCCCCCCCCCC=CC(O)=O FIKTURVKRGQNQD-UHFFFAOYSA-N 0.000 claims description 4
- 239000003429 antifungal agent Substances 0.000 claims description 4
- 239000000975 dye Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229940061720 alpha hydroxy acid Drugs 0.000 claims description 3
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 3
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 3
- 239000003443 antiviral agent Substances 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 125000002843 carboxylic acid group Chemical group 0.000 claims 1
- 150000001261 hydroxy acids Chemical class 0.000 claims 1
- 239000000155 melt Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 11
- 239000000047 product Substances 0.000 description 32
- 239000000243 solution Substances 0.000 description 24
- 230000009918 complex formation Effects 0.000 description 14
- 230000003993 interaction Effects 0.000 description 14
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 11
- 239000012141 concentrate Substances 0.000 description 11
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 11
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 11
- 239000000839 emulsion Substances 0.000 description 10
- 230000036571 hydration Effects 0.000 description 10
- 238000006703 hydration reaction Methods 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 10
- 230000002209 hydrophobic effect Effects 0.000 description 9
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 235000010980 cellulose Nutrition 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 229940097362 cyclodextrins Drugs 0.000 description 7
- 239000003945 anionic surfactant Substances 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002736 nonionic surfactant Substances 0.000 description 6
- -1 nonylphenyl Chemical group 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000002280 amphoteric surfactant Substances 0.000 description 5
- 230000000843 anti-fungal effect Effects 0.000 description 5
- 239000003093 cationic surfactant Substances 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 235000011399 aloe vera Nutrition 0.000 description 4
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical class OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 4
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229940119743 dextran 70 Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- IEORSVTYLWZQJQ-UHFFFAOYSA-N 2-(2-nonylphenoxy)ethanol Chemical compound CCCCCCCCCC1=CC=CC=C1OCCO IEORSVTYLWZQJQ-UHFFFAOYSA-N 0.000 description 3
- 241001116389 Aloe Species 0.000 description 3
- 239000001116 FEMA 4028 Substances 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 206010058667 Oral toxicity Diseases 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 229960004853 betadex Drugs 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920000847 nonoxynol Polymers 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 231100000418 oral toxicity Toxicity 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- MCCACAIVAXEFAL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 MCCACAIVAXEFAL-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- 229920000945 Amylopectin Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- 239000003139 biocide Substances 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000013626 chemical specie Substances 0.000 description 2
- 229960004022 clotrimazole Drugs 0.000 description 2
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 2
- 238000010668 complexation reaction Methods 0.000 description 2
- 230000007682 dermal toxicity Effects 0.000 description 2
- 229960001673 diethyltoluamide Drugs 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 229920001002 functional polymer Polymers 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000000077 insect repellent Substances 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 229960005040 miconazole nitrate Drugs 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 231100000438 skin toxicity Toxicity 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 238000000954 titration curve Methods 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- AFNXATANNDIXLG-SFHVURJKSA-N 1-[(2r)-2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound C1=CC(Cl)=CC=C1CS[C@H](C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 AFNXATANNDIXLG-SFHVURJKSA-N 0.000 description 1
- VHWSRELATOUTAG-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-aminobenzoate Chemical compound NC1=CC=CC=C1C(=O)OCC(O)CO VHWSRELATOUTAG-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- WVCHIGAIXREVNS-UHFFFAOYSA-N 2-hydroxy-1,4-naphthoquinone Chemical compound C1=CC=C2C(O)=CC(=O)C(=O)C2=C1 WVCHIGAIXREVNS-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 244000166675 Cymbopogon nardus Species 0.000 description 1
- 235000018791 Cymbopogon nardus Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229940022682 acetone Drugs 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229940024874 benzophenone Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000009133 cooperative interaction Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- CBZHHQOZZQEZNJ-UHFFFAOYSA-N ethyl 4-[bis(2-hydroxypropyl)amino]benzoate Chemical compound CCOC(=O)C1=CC=C(N(CC(C)O)CC(C)O)C=C1 CBZHHQOZZQEZNJ-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000010647 garlic oil Substances 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- CSFWPUWCSPOLJW-UHFFFAOYSA-N hydroxynaphthoquinone Natural products C1=CC=C2C(=O)C(O)=CC(=O)C2=C1 CSFWPUWCSPOLJW-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920004918 nonoxynol-9 Polymers 0.000 description 1
- 229940087419 nonoxynol-9 Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 229950000516 padimate Drugs 0.000 description 1
- LXTZRIBXKVRLOA-UHFFFAOYSA-N padimate a Chemical compound CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 LXTZRIBXKVRLOA-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- UWAAFUVSRWSVSK-UHFFFAOYSA-N phenoxybenzene;hydrochloride Chemical compound Cl.C=1C=CC=CC=1OC1=CC=CC=C1 UWAAFUVSRWSVSK-UHFFFAOYSA-N 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960002607 sulconazole Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- FBWNMEQMRUMQSO-UHFFFAOYSA-N tergitol NP-9 Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 FBWNMEQMRUMQSO-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000583 toxicological profile Toxicity 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1
- 229940030300 trolamine salicylate Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- WHGYBXFWUBPSRW-FEYSZYNQSA-N β-dextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)C(O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FEYSZYNQSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8164—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Virology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
本発明により使用され得る疎水性ポリマー組成物は、ピロリドン/アルキレン繰返し残基を含む。ピロリドン/アルキレン繰返し残基を含むポリマーの例には、ポリ(ビニルピロリドン/アルキレン)ポリマーが含まれる。ポリ(ビニルピロリドン/アルキレン)ポリマーは、アルキレン置換ビニルピロリドンの重合によって得られるポリマーが含まれる。ポリマーは、次の一般式で表すことができる。
本発明により使用され得る親水性ポリマー組成物は、少なくとも1つの親水性ポリマーを含み、親水性ポリマーの混合物を含んでいてもよい。本発明により使用され得る親水性ポリマーは、繰返しカルボン酸残基および/または水酸基を有するポリマーを含む。本発明により使用され得る好ましい親水性ポリマーは、ポリアクリル酸ポリマーおよびポリ(マレイン酸/メチルビニルエーテル)コポリマーを含む。
疎水性ポリマー組成物および親水性ポリマー組成物は、好ましくは、混合され、少なくとも約50℃に加熱されて、ポリマー溶融物を与える。組成物は、好ましくは、混合下で少なくとも約125℃に加熱されて、疎水性ポリマーと親水性ポリマーとの間で錯体が形成されることが好ましい。
局所組成物使用溶液は、好ましくは、局所組成物濃縮物を、使用溶液を生成するための添加成分と混合することによって調製される。使用溶液の生成のために組成物に導入され得る成分は、局所組成物産業において通常見られる成分を含む。成分の例には、抗菌剤、抗真菌剤、抗炎症剤、抗ウイルス剤、日焼け止め、ビタミン、α−ヒドロキシ酸、界面活性剤、色素(pigment)および色素(dyes)が含まれる。本発明の組成物に対して一般に最も好適な成分は、疎水性、アルコールなどの中性、および酸性という特徴を有し得る活性成分を含む。
1%以下の架橋を有する重量平均分子量400,000〜500,000のポリアクリル酸と、重量平均分子量1,980,000のマレイン酸/メチルビニルエーテルコポリマー(MMVE)とを使用した。低い溶液粘度による取扱いの簡便性および容易性のため、実験の大部分はMMVEを用いて実施した。酸性ポリマーは、遊離−COOH基の単純なpH滴定によって、より容易に研究される。10重量%まで濃度を増大させたPVPEを、75℃〜125℃の温度、無水条件下で、MMVEまたはPAと混合すると、半透明、黄褐色のワックス状固体または高粘度液体が得られる。水中で65℃に加熱すると、ポリマー濃度10〜15%の懸濁液が得られ、これは標準KOHで滴定することができた。結果を、図1に示す。同様にして調製されたMMVEおよびPVPHの混合物が与える結果を、図2に示す。
ポリマー研究のための別のツールは粘度である。我々は、温度の関数として、様々な濃度のPVPEおよびPVPH濃度での粘度測定値を観察することによって、錯体についての更なる情報を知ることを希望した。図5は、温度範囲32℃〜65℃、pH8.0で、PVPEまたはPVPH濃度0〜10%での、100mg/mlの水中ポリマー濃度での、この研究の結果を示す。
本発明に係るポリマー組成物は、洗い流しに対して耐性を有する皮膚への結合を意図しているため、我々は、ポリマー系の皮膚適用をまねた容易且つ迅速な重量測定方法を開発した。この試験は、溶媒の濾過に通常使用される親水性ナイロン膜を利用する。この膜は、皮膚に似た親水性と疎水性とが混じりあった特性を示す。
Claims (30)
- (a)ポリ(ビニルピロリドン/アルキレン)ポリマーを含み、前記アルキレンは少なくとも約10個の炭素原子を含むものである疎水性ポリマー組成物と、
(b)下記(i)〜(xi)の少なくとも1種を含む親水性ポリマー組成物との溶融加工の結果物を含み、
(i)少なくとも約50,000の重量平均分子量を有し、1%以下の架橋を示すポリアクリル酸、
(ii)少なくとも約50,000の重量平均分子量を有するポリ(マレイン酸/メチルビニルエーテル)コポリマー、
(iii)デンプン、
(iv)デンプン誘導体、
(v)セルロース、
(vi)セルロース誘導体、
(vii)カルボキメチルセルロース、
(viii)ポリビニルアルコール、
(ix)シクロデキストリン、
(x)デキストラン、
(xi)これらの混合物
(c)約1重量%以下の水を含む局所組成物前駆体。 - 疎水性ポリマー組成物が、少なくとも異なるポリ(ビニルピロリドン/アルキレン)ポリマーを含み、各ポリマーのアルキレン基が少なくとも10個の炭素原子を含む、請求項1に記載の局所組成物前駆体。
- 少なくとも2種の異なるポリ(ビニルピロリドン/アルキレン)ポリマーが、第1のポリ(ビニルピロリドン/アルキレン)ポリマーと、第2のポリ(ビニルピロリドン/アルキレン)ポリマーとを含み、前記第1のポリ(ビニルピロリドン/アルキレン)ポリマーが、疎水性ポリマー組成物の重量を基準として、約5重量%〜約54重量%の濃度で供される、請求項2に記載の局所組成物前駆体。
- 親水性ポリマー組成物が、約50,000〜約4,000,000の重量平均分子量を有するポリアクリル酸を含む、請求項1に記載の局所組成物前駆体。
- ポリ(マレイン酸/メチルビニルエーテル)コポリマーが、約50,000〜4,000,000の重量平均分量を有する、請求項1に記載の局所組成物前駆体。
- ポリ(ビニルピロリドン/アルキレン)ポリマーが、ポリ(ビニルピロリドン/1−エイコセン)を含む、請求項1に記載の局所組成物前駆体。
- ポリ(ビニルピロリドン/アルキレン)ポリマーが、ポリ(ビニルピロリドン/ヘキサデセン)を含む、請求項1に記載の局所組成物前駆体。
- 疎水性ポリマー組成物と親水性ポリマー組成物との官能基パリティ(functional group parity)は、約1:1〜約5:1の比で与えられる、請求項1に記載の局所組成物前駆体。
- 疎水性ポリマー組成物と親水性ポリマー組成物との官能基パリティは、約1.5:1〜約3:1の比で与えられる、請求項1に記載の局所組成物前駆体。
- 局所組成物前駆体の重量を基準として、疎水性ポリマー組成物が約72重量%〜約98重量%の濃度で供され、親水性ポリマーが約2重量%〜約25重量%の濃度で供される、請求項1に記載の局所組成物前駆体。
- (a)(i)繰返しピロリドン/アルキレン基を含み、前記アルキレン基は少なくとも約10個の炭素原子を含む疎水性ポリマー組成物と、(ii)繰返しカルボキシル基および/または繰返し水酸基を含む親水性ポリマー組成物との溶融加工の結果物であって、(iii)前記繰返しピロリドン/アルキレン基と、前記繰返しカルボキシル基および/または前記繰返し水酸基との比が、約1:1〜約5:1で与えられる結果物と、
(b)少なくとも約30重量%の水との溶融加工の結果物を含む局所組成物。 - 組成物が、約30重量%〜約45重量%の水を含む、請求項11に記載の局所組成物。
- 組成物が、約3重量%〜約10重量%の親水性ポリマー組成物と、約30重量%〜約50重量%の疎水性ポリマー組成物とを含む、請求項11に記載の局所組成物。
- 局所組成物が、約70重量%〜約96重量%の水を含む、請求項11に記載の局所組成物。
- 局所組成物が、抗菌剤、抗真菌剤、抗炎症剤、抗ウイルス剤、日焼け止め、ビタミン、α−ヒドロキシ酸、薬剤、界面活性剤、色素(dyes)、香料および色素(pigment)の少なくとも1種を含む、請求項11に記載の局所組成物。
- 疎水性ポリマー組成物が、少なくとも2種の異なるポリ(ビニルピロリドン/アルキレン)ポリマーを含み、各ポリマーのアルキレン基が、少なくとも約10個の炭素原子を含む、請求項11に記載の局所組成物。
- 疎水性ポリマー組成物が、
(a)少なくとも約50,000の重量平均分子量を有し、1%以下の架橋を示すポリアクリル酸、
(b)少なくとも約50,000の重量平均分子量を有するポリ(マレイン酸/メチルビニルエーテル)コポリマー、
(c)デンプン、
(d)デンプン誘導体、
(e)セルロース、
(f)セルロース誘導体、
(g)カルボキメチルセルロース、
(h)ポリビニルアルコール、
(i)シクロデキストリン、
(j)デキストラン、および
(k)これらの混合物
の少なくとも1種を含む、請求項11に記載の局所組成物。 - 親水性ポリマー組成物が、約50,000〜約4,000,000の重量平均分子量を有し、1%以下の架橋を示すポリアクリル酸を含む、請求項11に記載の局所組成物。
- 親水性ポリマー組成物が、約50,000〜4,000,000の重量平均分量を有するポリ(マレイン酸/メチルビニルエーテル)コポリマーを含む、請求項11に記載の局所組成物。
- 組成物が、更に、約0.5重量%〜約5重量%の界面活性剤を含む、請求項11に記載の局所組成物。
- 界面活性剤が、エトキシル化界面活性剤、プロポキシル化界面活性剤、エトキシル化‐プロポキシル化界面活性剤およびそれらの混合物の少なくとも1種を含む、請求項20に記載の局所組成物。
- 局所組成物の製造方法であって、
(a)(i)繰返しピロリドン/アルキレン基を含み、前記アルキレン基が少なくとも10個の炭素原子を含む疎水性ポリマー組成物と、(ii)繰返しカルボン酸基および/または繰返し水酸基を含む親水性ポリマー組成物と、(iii)1重量%以下の水とを含む混合物を溶融加工して、局所組成物前駆体を得る工程と、
(b)前記局所組成物前駆体を希釈して、水濃度を、局所組成物の重量を基準として、少なくとも約30重量%とする工程とを含む方法。 - 更に、(a)局所組成物に少なくとも1種の活性成分を添加する工程を含み、前記活性成分が、抗菌剤、抗真菌剤、抗炎症剤、抗ウイルス剤、薬剤、日焼け止め、ビタミン、α−ヒドロキシ酸、界面活性剤、香料、色素(pigment)および色素(dyes)の少なくとも1種を含む、請求項22に記載の方法。
- 溶融加工する工程が、疎水性ポリマー組成物と親水性ポリマー組成物とを、50℃以上の温度で混合することを含む、請求項22に記載の方法。
- 溶融加工する工程が、疎水性ポリマー組成物と親水性ポリマー組成物とを、125℃以上の温度で混合することを含む、請求項22に記載の方法。
- 更に、(a)局所組成物前駆体を水で希釈して、局所組成物の重量を基準として、約30重量%〜約45重量%の水を含む組成物を得る工程を含む、請求項22に記載の方法。
- 更に、(a)局所組成物を別の工程で更に希釈して、局所組成物の重量を基準として、少なくとも約95重量%の水を含む組成物を得る工程を含む、請求項26に記載の方法。
- 更に、(a)局所組成物に界面活性剤を添加する工程を含む、請求項22に記載の方法。
- 界面活性剤が、エトキシル化界面活性剤、プロポキシル化界面活性剤、エトキシル化−プロポキシル化界面活性剤およびそれらの混合物の少なくとも1種を含む、請求項28に記載の方法。
- 局所組成物の使用方法であって、(a)皮膚組織に局所組成物を適用する工程を含み、前記局所組成物が、約1重量%以下の水濃度で、
(i)繰返しピロリドン/アルキレン基を含み、前記アルキレン基が少なくとも10個の炭素原子を含む疎水性ポリマー組成物と、
(ii)繰返しカルボキシル基および/または繰返し水酸基を含む親水性ポリマー組成物とを、
(iii)繰返しピロリドン/アルキレン基と、繰返しカルボキシル基および/または繰返し水酸基との比が、約1:1〜約5:1で与えられるように、溶融加工した結果物を含み、
少なくとも約30重量%の水の水濃度に水和されたものである方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/933,275 US6756059B2 (en) | 2001-08-20 | 2001-08-20 | Topical composition, topical composition precursor, and methods for manufacturing and using |
PCT/US2002/026301 WO2003015821A1 (en) | 2001-08-20 | 2002-08-16 | Topical composition, topical composition precursor, and methods for manufacturing and using |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005526147A true JP2005526147A (ja) | 2005-09-02 |
JP2005526147A5 JP2005526147A5 (ja) | 2006-01-05 |
JP4210592B2 JP4210592B2 (ja) | 2009-01-21 |
Family
ID=25463664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003520779A Expired - Fee Related JP4210592B2 (ja) | 2001-08-20 | 2002-08-16 | 局所組成物、局所組成物前駆体、並びに、その製造および使用方法 |
Country Status (10)
Country | Link |
---|---|
US (5) | US6756059B2 (ja) |
EP (1) | EP1425044B1 (ja) |
JP (1) | JP4210592B2 (ja) |
KR (1) | KR100942859B1 (ja) |
CN (1) | CN100506278C (ja) |
AT (1) | ATE545405T1 (ja) |
AU (1) | AU2002355964B2 (ja) |
CA (1) | CA2457124C (ja) |
HK (1) | HK1066971A1 (ja) |
WO (1) | WO2003015821A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011509929A (ja) * | 2008-01-14 | 2011-03-31 | レキット アンド コールマン (オーヴァーシーズ) リミテッド | 疎水性粒子を含む除毛組成物、その調製方法及び使用方法 |
JP6083773B1 (ja) * | 2016-05-20 | 2017-02-22 | 秋山錠剤株式会社 | 脱臭塗膜と該脱臭塗膜の成膜方法および脱臭面保有設備機器 |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6756059B2 (en) * | 2001-08-20 | 2004-06-29 | Skinvisible Pharmaceuticals, Inc. | Topical composition, topical composition precursor, and methods for manufacturing and using |
AU2002950506A0 (en) * | 2002-07-31 | 2002-09-12 | Soltec Research Pty Ltd | Percutaneous delivery system |
US20040126339A1 (en) * | 2002-12-31 | 2004-07-01 | Roszell James A. | Sunscreen composition and methods for manufacturing and using a sunscreen composition |
US20050036958A1 (en) * | 2003-08-13 | 2005-02-17 | Jianxun Feng | Dental bleaching |
US20050048105A1 (en) * | 2003-08-29 | 2005-03-03 | Mcnulty Amy K. | Protease inhibitor compositions for prevention and treatment of skin conditions |
US20050066463A1 (en) * | 2003-09-25 | 2005-03-31 | Brunner Michael S. | Substrates and devices for applying a lip care formulation |
US20060045857A1 (en) * | 2004-09-02 | 2006-03-02 | Roszell James A | Sunless tanning composition and methods for using |
CA2599609C (en) * | 2005-03-03 | 2013-08-13 | Covidien Ag | Medical treatment device and method for manufacturing the same |
US20060251593A1 (en) * | 2005-04-07 | 2006-11-09 | Work By Docs, Inc. | Colored nail enamel treatment |
US20060246021A1 (en) * | 2005-05-02 | 2006-11-02 | Roszell James A | Sunless tanning composition and methods for using |
US20070160559A1 (en) * | 2006-01-12 | 2007-07-12 | Roszell James A | Skin disinfectant composition and methods for using |
US20090215888A1 (en) * | 2006-03-02 | 2009-08-27 | Singh Jagat | Topical nail formulation |
US20070258935A1 (en) * | 2006-05-08 | 2007-11-08 | Mcentire Edward Enns | Water dispersible films for delivery of active agents to the epidermis |
US20070259029A1 (en) * | 2006-05-08 | 2007-11-08 | Mcentire Edward Enns | Water-dispersible patch containing an active agent for dermal delivery |
US20080057090A1 (en) * | 2006-09-01 | 2008-03-06 | Mcentire Edward Enns | Wrinkle masking film composition for skin |
US7879942B2 (en) * | 2006-10-05 | 2011-02-01 | Eastman Chemical Company | Switchable adhesive article for attachment to skin and method of using the same |
US20100137333A1 (en) * | 2006-10-20 | 2010-06-03 | Roszell James A | Antifungal composition and methods for using |
WO2008051461A2 (en) * | 2006-10-20 | 2008-05-02 | Skinvisible Pharmaceuticals, Inc. | Acne treatment composition and methods for using |
US9393261B2 (en) | 2011-07-22 | 2016-07-19 | Body Glide LLC | Antimicrobial anti-chafing chelated silver oxide compound |
US9132296B2 (en) | 2007-05-17 | 2015-09-15 | Ag Essence | Antimicrobial solution and methods of making and using the same |
CN101873845A (zh) * | 2007-10-11 | 2010-10-27 | 麦克内尔-Ppc股份有限公司 | 改良的局部镇痛产品 |
US8128913B1 (en) | 2007-12-06 | 2012-03-06 | Skinvisible Pharmaceuticals, Inc. | Sunscreen composition with enhanced UV-A absorber stability and methods |
US8299122B2 (en) * | 2008-04-14 | 2012-10-30 | Skinvisible Pharmaceuticals, Inc. | Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition |
WO2010091274A1 (en) * | 2009-02-06 | 2010-08-12 | Skinvisible Pharmaceuticals, Inc. | A cationic pharmaceutically active ingredient containing composition, and methods for manufacturing and using |
EP2536274A1 (en) * | 2010-02-19 | 2012-12-26 | Skinvisible Pharmaceuticals, Inc. | Skin disinfectant composition and methods for manufacturing and using |
CN101957363A (zh) * | 2010-09-13 | 2011-01-26 | 南京卡博生物科技有限公司 | 胶乳免疫比浊检测用样本处理液 |
AU2011338199A1 (en) | 2010-12-10 | 2013-05-23 | Skinvisible Pharmaceuticals, Inc. | Compositions for treating dermatitis and ichthyosis, and methods for treating dermatitis and ichthyosis |
US11547116B2 (en) | 2012-12-12 | 2023-01-10 | William Wingfield | Metal oxide compounds and infusion into polymer compounds |
US11166980B2 (en) * | 2016-04-13 | 2021-11-09 | Novan, Inc. | Compositions, systems, kits, and methods for treating an infection |
CA3074150A1 (en) | 2020-02-18 | 2021-08-18 | Ovation Science, Inc. | Composition and method for transdermal delivery of cannabidiol (cbd) and delta9-tetrahydrocannabinol (thc) |
Family Cites Families (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3817887A (en) * | 1972-03-09 | 1974-06-18 | Gaf Corp | Adhesive stick comprising an alkylated n-vinylpyrrolidone polymer |
US4035506A (en) | 1974-07-26 | 1977-07-12 | Minnesota Mining And Manufacturing Company | Fluorocarbon dermal protective compositions |
US4440741A (en) | 1977-10-25 | 1984-04-03 | Colgate-Palmolive Company | Bicarbonate-containing stick deodorant |
JPS5564512A (en) | 1978-11-11 | 1980-05-15 | Kanebo Ltd | Cosmetic composition of oil-in-water emulsion |
DE3066625D1 (en) | 1979-11-05 | 1984-03-22 | Ici Plc | Slurry explosive composition and a method for the preparation thereof |
US4301145A (en) | 1980-07-28 | 1981-11-17 | Cestari Joseph E | Antiseptic skin cream |
US4500338A (en) | 1980-09-03 | 1985-02-19 | Young Robert W | Adherent controlled release microbiocides containing hydrolyzable _organic titanium compounds |
US4448906A (en) | 1982-06-16 | 1984-05-15 | Nuodex Inc. | Surface-coating compositions |
US4645794A (en) | 1983-10-07 | 1987-02-24 | Ici Americas Inc. | Quaternary nitrogen containing polyvinyl alcohol polymers for use in skin conditioning, cosmetic and pharmaceutical formulations |
IL77224A (en) | 1984-12-12 | 1989-09-10 | Euro Celtique Sa | Antibacterial cream |
US5266329A (en) | 1985-10-31 | 1993-11-30 | Kv Pharmaceutical Company | Vaginal delivery system |
US5955109A (en) | 1985-12-18 | 1999-09-21 | Advanced Polymer Systems, Inc. | Methods and compositions for topical delivery of retinoic acid |
GB8607159D0 (en) | 1986-03-22 | 1986-04-30 | Smith & Nephew Ass | Pharmaceutical composition |
GB8620895D0 (en) | 1986-08-29 | 1986-10-08 | Unilever Plc | Cosmetic stick |
US4840687A (en) * | 1986-11-14 | 1989-06-20 | The Lubrizol Corporation | Explosive compositions |
US4897259A (en) | 1986-12-04 | 1990-01-30 | Bristol-Myers Company | High oil phase pharmaceutical vehicles and sunscreen compositions having waterproof sun protection factors |
US4810489A (en) | 1986-12-04 | 1989-03-07 | Bristol-Myers Company | High oil phase pharmaceutical vehicles and sunscreen compositions having waterproof sun protection factors |
US5082656A (en) | 1987-04-30 | 1992-01-21 | Abbott Laboratories | Topical antibacterial compositions containing penetration enchancers |
US5051260A (en) | 1987-07-16 | 1991-09-24 | The Regents Of The University Of California | Method and composition for enhancing the cutaneous penetration of pharmacologically active agents |
US5045317A (en) | 1987-07-16 | 1991-09-03 | The Regents Of The University Of California | Enhancing the cutaneous penetration of pharmacologically active agents |
US4971800A (en) | 1988-07-08 | 1990-11-20 | The Regents Of The University Of California | Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents |
US5126136A (en) | 1988-08-05 | 1992-06-30 | Merat Pierre H | Skin protection lotion |
JPH02121907A (ja) | 1988-10-31 | 1990-05-09 | Mitsubishi Heavy Ind Ltd | 人用化粧料 |
US5055303A (en) | 1989-01-31 | 1991-10-08 | Kv Pharmaceutical Company | Solid controlled release bioadherent emulsions |
EP0391741B1 (en) | 1989-04-06 | 1995-04-19 | Merocel Corporation | Polymeric broad-spectrum antimicrobial materials |
US5232691A (en) | 1989-04-26 | 1993-08-03 | Lemole Gerald M | Protective gel composition |
US5019604A (en) | 1989-04-26 | 1991-05-28 | Lemole Gerald M | Protective gel composition |
US5674912A (en) | 1991-03-01 | 1997-10-07 | Warner-Lambert Company | Sunscreen-wound healing compositions and methods for preparing and using same |
US5869593A (en) | 1991-07-01 | 1999-02-09 | H. B. Fuller Licensing & Financing, Inc. | High moisture vapor transmission hot melt moisture cure polyurethane adhesive |
ATE160501T1 (de) | 1991-08-19 | 1997-12-15 | Procter & Gamble | Haarspraypraeparate |
IL105748A0 (en) | 1992-05-22 | 1993-09-22 | Int Research & Dev Corp | Topical antiperspirant composition |
WO1994013257A1 (en) | 1992-12-16 | 1994-06-23 | Creative Products Resource Associates, Ltd. | Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder |
US5320838A (en) | 1992-12-21 | 1994-06-14 | Pro Cure Products, Ltd. | Protectant for irritated skin containing polyethyleneglycols, polyvinylether salt anhydride and polyvinylpyrrolidone |
US5370876A (en) | 1993-01-08 | 1994-12-06 | Microbarriers | Antimicrobial protective skin composition and method for protecting skin from body fluids |
US5725844A (en) | 1993-02-11 | 1998-03-10 | Beiersdorf Ag | Waterproof cosmetic or dermatological photoprotective preparations |
US5431756A (en) * | 1993-02-25 | 1995-07-11 | Mach I, Inc. | Method and composition for melt cast explosives, propellants and pyrotechnics |
US5298534A (en) * | 1993-03-01 | 1994-03-29 | Isp Investments Inc. | Denture adhesive |
JP3615759B2 (ja) | 1993-04-16 | 2005-02-02 | シェーリング‐プラウ、ヘルスケア、プロダクツ、インコーポレーテッド | 人工日焼け色を形成して、uv光から皮膚を保護するための組成物 |
US5389363A (en) | 1993-04-23 | 1995-02-14 | Revlon Consumer Products Corporation | Cosmetic compositions for lengthening, coloring and curling eyelashes |
US5730966A (en) | 1993-07-01 | 1998-03-24 | The Procter & Gamble Company | Thermoplastic elastomeric copolymers used in hair and skin care compositions |
US5336305A (en) | 1993-07-06 | 1994-08-09 | International Laboratory Technology Corp. | Flexible material having barrier properties |
US5747022A (en) | 1993-07-30 | 1998-05-05 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Cosmetic mask |
US5417968A (en) | 1993-08-16 | 1995-05-23 | International Laboratory Technology Corp. | Antimicrobial barrier composition |
US5547662A (en) | 1993-08-27 | 1996-08-20 | Becton, Dickinson And Company | Preparation of a skin surface for a surgical procedure |
JPH0789826A (ja) * | 1993-09-21 | 1995-04-04 | Shiseido Co Ltd | 固型油性化粧料 |
DE4416927C1 (de) * | 1994-05-13 | 1995-08-31 | Lohmann Therapie Syst Lts | Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung |
US6074527A (en) | 1994-06-29 | 2000-06-13 | Kimberly-Clark Worldwide, Inc. | Production of soft paper products from coarse cellulosic fibers |
US5597849A (en) | 1994-11-14 | 1997-01-28 | Medical Polymer Technologies, Inc. | Stick formulations for topical drug delivery of therapeutic agents and uses thereof |
US5618850A (en) | 1995-03-09 | 1997-04-08 | Focal, Inc. | Hydroxy-acid cosmetics |
US5607979A (en) | 1995-05-30 | 1997-03-04 | The United States Of America As Represented By The Secretary Of The Army | Topical skin protectants |
AU722246B2 (en) | 1995-06-07 | 2000-07-27 | Johnson & Johnson Consumer Products, Inc. | Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same |
US5721306A (en) | 1995-06-07 | 1998-02-24 | Amcol International Corporation | Viscous carrier compositions, including gels, formed with an organic liquid carrier and a layered material:polymer complex |
US5605676A (en) | 1995-06-26 | 1997-02-25 | Colgate-Palmolive Company | Oral composition exhibiting improved uptake and retention of antibacterial compounds on dental tissue surfaces |
US6096344A (en) | 1995-07-28 | 2000-08-01 | Advanced Polymer Systems, Inc. | Bioerodible porous compositions |
DE19543989A1 (de) | 1995-11-25 | 1997-05-28 | Wella Ag | Blondiermittel für menschliche Haare |
US5968543A (en) | 1996-01-05 | 1999-10-19 | Advanced Polymer Systems, Inc. | Polymers with controlled physical state and bioerodibility |
US5707612A (en) | 1996-04-08 | 1998-01-13 | Alzo, Inc. | Use urethane polymers of castor oil skin and personal care product compositiions |
US5736128A (en) | 1996-05-14 | 1998-04-07 | Isp Investments Inc. | Cosmetic composition for rejuvenation of skin without skin irritation |
US5834538A (en) | 1996-06-18 | 1998-11-10 | Hercules Incorporated | Pressure sensitive adhesives |
US5911980A (en) | 1996-06-27 | 1999-06-15 | Macrochem Corporation | Lipophilic and amphiphilic or hydrophilic film-forming polymer compositions, and use thereof in topical agent delivery system and method of delivering agents to the skin |
FR2751212B1 (fr) | 1996-07-17 | 1998-11-06 | Oreal | Composition comprenant l'association d'un compose volatil et d'un copolymere de polyvinylpyrrolidone et d'alpha-olefines et utilisation de ladite association |
JPH1095714A (ja) | 1996-09-19 | 1998-04-14 | Sanei Kagaku Kk | 毛髪処理剤 |
US5807957A (en) | 1996-12-23 | 1998-09-15 | Macrochem Corporation | Cationic film-forming polymer compositions, and use thereof in topical agents delivery system and method of delivering agents to the skin |
KR20010013377A (ko) * | 1997-06-04 | 2001-02-26 | 데이비드 엠 모이어 | 마일드한 잔류성 항균 조성물 |
DK1007597T3 (da) * | 1997-08-29 | 2003-08-18 | Avery Dennison Corp | Absorberende trykfølsomme klæbere til biologiske væsker |
US5976566A (en) | 1997-08-29 | 1999-11-02 | Macrochem Corporation | Non-steroidal antiinflammtory drug formulations for topical application to the skin |
US5906822A (en) | 1997-09-25 | 1999-05-25 | Macrochem Corporation | Cationic film-forming polymer compositions, and use thereof in topical agents delivery system and method of delivering agents to the skin |
US5968919A (en) | 1997-10-16 | 1999-10-19 | Macrochem Corporation | Hormone replacement therapy drug formulations for topical application to the skin |
US6177068B1 (en) | 1997-12-10 | 2001-01-23 | Isp Investments Inc. | Vinyl amide polymer delivery system for hair and skin treating compositions |
US6255421B1 (en) | 1997-12-10 | 2001-07-03 | Isp Investments Inc. | Non-aqueous, heterogeneous polymerization process and reaction product obtained thereby |
DE29801018U1 (de) | 1998-01-23 | 1998-04-09 | MAN Roland Druckmaschinen AG, 63075 Offenbach | Stapelwender |
ES2278422T3 (es) | 1998-02-11 | 2007-08-01 | Beiersdorf Aktiengesellschaft | Agente para peinado de diseño, de base acuosa, conteniendo gamma-oryzanol y sales de calcio. |
US5891470A (en) | 1998-04-17 | 1999-04-06 | Advanced Polymer Systems, Inc. | Softgel formulation containing retinol |
US6649174B2 (en) | 1998-05-07 | 2003-11-18 | E-L Management Corp. | Dual phase cosmetic composition |
US5939453A (en) | 1998-06-04 | 1999-08-17 | Advanced Polymer Systems, Inc. | PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers |
US5942545A (en) | 1998-06-15 | 1999-08-24 | Macrochem Corporation | Composition and method for treating penile erectile dysfunction |
AU769224B2 (en) | 1998-12-28 | 2004-01-22 | Taisho Pharmaceutical Co., Ltd. | External preparation |
US6183766B1 (en) * | 1999-02-12 | 2001-02-06 | The Procter & Gamble Company | Skin sanitizing compositions |
WO2001017488A1 (en) | 1999-09-03 | 2001-03-15 | L'oreal Sa | Cosmetic compositions containing specific polysaccharide resins |
US6582683B2 (en) | 2000-01-04 | 2003-06-24 | Skinvisible Pharmaceuticals, Inc. | Dermal barrier composition |
FR2813528B1 (fr) | 2000-09-07 | 2004-02-27 | Oreal | Composition cosmetique, et son utilisation comme masque de nettoyage de la peau |
US6881400B2 (en) | 2000-12-12 | 2005-04-19 | L'oreal S.A. | Use of at least one polyamide polymer in a mascara composition for increasing the adhesion of and/or expressly loading make-up deposited on eyelashes |
US6756059B2 (en) | 2001-08-20 | 2004-06-29 | Skinvisible Pharmaceuticals, Inc. | Topical composition, topical composition precursor, and methods for manufacturing and using |
US20040126339A1 (en) | 2002-12-31 | 2004-07-01 | Roszell James A. | Sunscreen composition and methods for manufacturing and using a sunscreen composition |
US8128913B1 (en) | 2007-12-06 | 2012-03-06 | Skinvisible Pharmaceuticals, Inc. | Sunscreen composition with enhanced UV-A absorber stability and methods |
-
2001
- 2001-08-20 US US09/933,275 patent/US6756059B2/en not_active Expired - Lifetime
-
2002
- 2002-05-23 US US10/154,723 patent/US8481058B2/en not_active Expired - Lifetime
- 2002-08-16 KR KR1020047002561A patent/KR100942859B1/ko active IP Right Grant
- 2002-08-16 AU AU2002355964A patent/AU2002355964B2/en not_active Expired
- 2002-08-16 AT AT02752847T patent/ATE545405T1/de active
- 2002-08-16 CN CNB028163249A patent/CN100506278C/zh not_active Expired - Lifetime
- 2002-08-16 EP EP02752847A patent/EP1425044B1/en not_active Expired - Lifetime
- 2002-08-16 WO PCT/US2002/026301 patent/WO2003015821A1/en active Application Filing
- 2002-08-16 CA CA2457124A patent/CA2457124C/en not_active Expired - Lifetime
- 2002-08-16 JP JP2003520779A patent/JP4210592B2/ja not_active Expired - Fee Related
-
2004
- 2004-12-31 HK HK04110406.3A patent/HK1066971A1/xx not_active IP Right Cessation
-
2005
- 2005-03-14 US US11/079,158 patent/US8318818B2/en active Active
- 2005-08-15 US US11/204,808 patent/US7674471B2/en not_active Expired - Lifetime
-
2010
- 2010-03-08 US US12/660,982 patent/US20100173904A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011509929A (ja) * | 2008-01-14 | 2011-03-31 | レキット アンド コールマン (オーヴァーシーズ) リミテッド | 疎水性粒子を含む除毛組成物、その調製方法及び使用方法 |
JP6083773B1 (ja) * | 2016-05-20 | 2017-02-22 | 秋山錠剤株式会社 | 脱臭塗膜と該脱臭塗膜の成膜方法および脱臭面保有設備機器 |
Also Published As
Publication number | Publication date |
---|---|
US20030044374A1 (en) | 2003-03-06 |
US8318818B2 (en) | 2012-11-27 |
ATE545405T1 (de) | 2012-03-15 |
CN1545420A (zh) | 2004-11-10 |
CA2457124A1 (en) | 2003-02-27 |
JP4210592B2 (ja) | 2009-01-21 |
US20030044436A1 (en) | 2003-03-06 |
US7674471B2 (en) | 2010-03-09 |
US8481058B2 (en) | 2013-07-09 |
AU2002355964B2 (en) | 2008-05-22 |
EP1425044B1 (en) | 2012-02-15 |
US20050175571A1 (en) | 2005-08-11 |
US20050287097A1 (en) | 2005-12-29 |
CA2457124C (en) | 2011-10-11 |
HK1066971A1 (en) | 2005-03-18 |
WO2003015821A1 (en) | 2003-02-27 |
KR20040044191A (ko) | 2004-05-27 |
EP1425044A4 (en) | 2009-12-09 |
US6756059B2 (en) | 2004-06-29 |
EP1425044A1 (en) | 2004-06-09 |
CN100506278C (zh) | 2009-07-01 |
US20100173904A1 (en) | 2010-07-08 |
KR100942859B1 (ko) | 2010-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4210592B2 (ja) | 局所組成物、局所組成物前駆体、並びに、その製造および使用方法 | |
AU2002355964A1 (en) | Topical composition, topical composition precursor, and methods for manufacturing and using | |
US4927636A (en) | Association complex comprising pullulan and polyethylene glycol, and preparation and uses of the same | |
US9901527B2 (en) | Viscous composition | |
US6261544B1 (en) | Poly(hydroxy acid)/polymer conjugates for skin applications | |
CN103153277B (zh) | 聚合物和组合物 | |
US5580974A (en) | Microfibrillated oxycellulose dispersions | |
KR20010031274A (ko) | 폴리히드록실화 유기 화합물과 배합된 실질적으로무정형인 셀룰로스 나노피브릴의, 화장용 제제에서의 용도 | |
WO2004099259A1 (ja) | カチオン変性アルギン酸誘導体及び該物質を含む化粧料組成物 | |
CN107405288A (zh) | 衣康酸的聚合物及其在化妆品产品或个人护理产品中作为成膜剂的用途 | |
CA2578747A1 (en) | Low viscosity sunless tanning composition and methods for using | |
JPS6366107A (ja) | 乳化型化粧料 | |
WO2021209645A1 (en) | Composition for treating keratin tissue | |
CN117597148A (zh) | 非水膨润性的皮膜形成型外用剂基剂 | |
JP2012097052A (ja) | 冷感剤組成物 | |
US20140148407A1 (en) | Aqueous gels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050707 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050707 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20080125 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080207 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080422 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080430 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080527 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080603 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080624 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080701 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080806 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080904 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081003 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20081014 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20081027 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111031 Year of fee payment: 3 |
|
LAPS | Cancellation because of no payment of annual fees |